Evidence map›Paper›PMID 30644014›Full record

ArticleJournal of clinical immunology2019

Childhood Hodgkin Lymphoma: Think DADA2.

Fahad Alabbas, Ghaleb Elyamany, Omar Alsharif, Michael Hershfield, Isabelle Meyts

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Mimics and challenging presentations of DADA2.Clinical and experimental immunology · 2025
    Review
  6. Human ADA2 Deficiency: Ten Years Later.Current allergy and asthma reports · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fahad AlabbasDepartment of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City (PSMMC), Sulimaniyah RD, Riyadh, 12233, Saudi Arabia. Fmabbas@psmmc.med.sa.ORCID 0000-0001-6910-1369
Ghaleb ElyamanyPrince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia.
Omar AlsharifDepartment of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City (PSMMC), Sulimaniyah RD, Riyadh, 12233, Saudi Arabia.
Michael HershfieldDepartment of Medicine and Biochemistry, Duke University Medical Center, Durham, NC, USA.
Isabelle MeytsDepartment of Pediatrics, Department of Microbiology and Immunology, University Hospitals Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenosine DeaminaseChild, PreschoolHodgkin DiseaseHumansLymphomaMaleAdenosine Deaminase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.